Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer
Clinical trial NCT02820961 · COMPLETED
Trial details
- NCT number
- NCT02820961
- Sponsor
- Syndax Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-29
- Primary completion
- 2018-09-10
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.